GE HealthCare unveils Allia Moveo, designed to deliver next-level mobility, workflow and comfort in the interventional suite

Key Terms

c-arm technical

A C-arm is a mobile medical X‑ray machine shaped like the letter “C” that provides live, real‑time images during procedures such as surgeries and diagnostic tests. Investors care because sales, upgrades, and hospital purchases of C‑arms drive revenue for medical device makers and signal demand for capital spending by healthcare providers; adoption and reimbursement trends affect companies’ growth and the expected lifespan of installed equipment, similar to how new tools change productivity in a factory.

cone beam computed tomography medical

Cone beam computed tomography (CBCT) is a type of medical X-ray scanner that produces a detailed three-dimensional image of the head, jaw, teeth and surrounding bone by rotating a cone-shaped beam around the patient. For investors, CBCT matters because it drives sales of specialized imaging equipment, affects how accurately procedures are planned and billed, and influences clinic capital spending and reimbursement trends—factors that can change revenue and profit outlooks for healthcare and device companies.

cbct medical

Cone beam computed tomography (CBCT) is a type of 3D X‑ray scan that creates detailed, three‑dimensional images of teeth, jaws and facial bones by rotating a cone‑shaped X‑ray beam around the head. For investors, CBCT matters because it drives demand for specialized imaging equipment, software and clinics; changes in adoption, reimbursement or regulatory approval can directly affect revenues and margins in dental and medical device businesses. Think of it as upgrading from a flat photo to a full 3D model that clinicians use to plan treatment more precisely.

interventional suite medical

An interventional suite is a specialized hospital room equipped with advanced imaging and tools for performing minimally invasive, image-guided procedures such as catheter-based heart or vascular treatments and targeted biopsies. Investors should care because these suites enable higher-margin, outpatient-friendly services, increase a facility’s procedure capacity and patient throughput, and often require significant capital investment—similar to adding a high-tech workshop that expands what a business can make and how quickly it can serve customers.

artificial intelligence technical

Artificial intelligence is the ability of computers and machines to perform tasks that typically require human thinking, such as understanding language, recognizing patterns, or making decisions. For investors, it matters because AI can enhance efficiency, uncover new insights, and enable smarter strategies, potentially impacting the value and performance of companies that develop or utilize this technology.

ai-powered technical

"AI-powered" describes technology that uses artificial intelligence to perform tasks, make decisions, or analyze information automatically. It’s similar to having a highly skilled assistant that can learn from data, recognize patterns, and improve over time, helping to make processes faster and more accurate. For investors, this means better insights and more efficient operations, potentially leading to smarter investment choices.

augmented guidance technical

Augmented guidance is an expanded version of a company’s forecast that adds extra detail beyond a single revenue or profit number — for example ranges, key assumptions, sensitivity to different scenarios, or breakouts of important metrics. It matters to investors because the extra context reduces guesswork and lets them update valuations more accurately, like getting a weather forecast with temperature, wind and chance of rain instead of just “sunny.”

510(k) pending regulatory

510(k) pending means a medical device maker has submitted a premarket filing to the U.S. Food and Drug Administration asking to sell a device by showing it is similar to an already approved product, and the agency has not yet given clearance. For investors this signals that the product cannot be marketed or widely sold until clearance arrives, so revenue, timing and approval risk are still uncertain—like a car waiting for its roadworthy certificate before it can be driven off the lot.

• Compact, cable-free C-arm aims to maximize space and movement and allow greater flexibility and accessibility for everyday performance
• Patient-centric design featuring lateral wide-bore cone beam computed tomography with the goal of enhancing image quality to accommodate a range of patients and procedures for more inclusive care
• Built to empower clinicians with a future-ready environment aimed to provide enhanced efficiency and versatility, enabling improved patient outcomes

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today unveiled the Allia™ Moveoⁱ, an image guiding solution designed to enhance mobility and flexibility and redefine the way clinicians deliver care in the interventional suite. This new Allia platform features a slim, compact, cable-free C-arm, allowing full movement and patient access, while aiming to deliver outstanding image quality. To help care teams work with ease, Allia Moveo features a wide-bore C-arm designed to enable cone beam computed tomography (CBCT) that accommodates a diverse patient population, an ergonomic design and AI-powered tools intended to provide a seamless workflow, offering patients a smooth, more personalized procedure.

“As demand for minimally invasive procedures continues to increase, clinicians are navigating greater complexities and volume, and need technology that keeps pace to enhance precision, simplify workflows, and support efficient care delivery,” said Philip Rackliffe, President and CEO, Advanced Visualization Solutions (AVS) at GE HealthCare. “Allia Moveo aims to set a new standard in interventional care, reduce barriers, and anticipate clinical needs, with the goal of empowering clinicians to deliver optimal patient outcomes with comfort and confidence.”

Clinicians perform nearly half of interventional procedures from working positions where they struggle with limited access to essential controls, displays, and interfaces.ⁱⁱ The unique design of Allia Moveo aims to ensure full access to the patient during both simple and complex procedures and includes thoughtful placement of motion controls—comfortably accessible from nearly any position—so clinicians can focus on what matters most: the procedure and the patient. These comfort-enhancing features also extend to patients, who may benefit from the wide bore and effortless table panning, which is designed to provide a smooth experience regardless of weight or body size.

In addition, Allia Moveo includes new features designed to enhance efficiency, like SmartMove, which allows the clinician to move the C-arm away from the patient whenever needed and return it to its original position at the press of a button, developed to minimize setup time and workflow interruptions. Artificial intelligence and augmented guidance tools also support advanced workflow with the goal of enabling greater precision. Like other Allia IGS systems, Allia Moveo is intended to sit at the center of the interventional ecosystem and supports multi-modality integrations across a wide range of imaging and diagnostic technologies that enable care teams to tailor their environment to the unique needs of each procedure.

“Allia Moveo is more than a new interventional system - it represents our boldest innovations yet, designed with intention and shaped by years of collaboration with interventionalists and surgeons,” said Jyoti Gera, Chief Executive Officer, CardioVascular and Interventional Solutions, AVS at GE HealthCare. “Created for and by clinicians, it is built to deliver agility, flexibility, and a reimagined workflow aimed at unlocking new levels of ease, efficiency, and precision care.”

Allia Moveo is currently FDA 510(k) pending. This product may not be available in all regions, contact your GE HealthCare sales representative for more information. To learn more about GE HealthCare’s Allia IGS platform, visit booth #7334 at RSNA, explore the press kit, or the RSNA 2025 events page.

About GE HealthCare Technologies Inc.

GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2025 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

ⁱ 510(k) pending with the U.S. FDA. Not available for sale in the US. Not CE Marked.

ⁱⁱ According to GE HealthCare sponsored blind survey conducted with 180 interventional cardiologists, interventional radiologists, and vascular surgeons in the U.S. and Europe.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251201255383/en/

GE HealthCare Media Contact:

Eric Tatro

GE HealthCare

+1 312 459 6140

Eric.Tatro@gehealthcare.com

Source: GE HealthCare